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Previous studies identified autoantibodies against the 
IgE high affinity receptor a-chain, FceRIa, in sera of 
selected patients with severe chronic idiopathic urti-
caria. We have now determined the incidence of 
anti-FceRIa autoantibodies in a group of 163 pa-
tients. Intradermal injection of autologous serum 
caused skin reactions indicative of mast cell degran-
ulation in 98 (60%) patients. Based on histamine 
release from IgE-sensitized and nonsensitized baso-
phil leukocytes of healthy donors, we detected anti-
FceRIa autoantibodies in sera from 38 (23%) urticaria 
patients and evidence for anti-IgE antibodies in a 
further nine patients. The sera that released hista-
n:J.rne from basophils induced histamine release (4-
34%, n = 12) from mast cells in incubated skin slices. 
Protein-G affinity chromatography of sera demon-
strated that mast cell histamine release was IgG-
A ltho ug h m ast ce ll degranulatio n and m ediato r release arc strongly implicated in the pathogenesis of chronic idio pa thic urti caria, a specific antigenic stim-ulus C'1I1 rarely be idcntiflCd (Champion, 1990). T he induc tion of an immediate type w hca l and fl are 
reaction 111 many urti ca ri a paticnts on intradermal injection of 
autologous serum is indicative of circulating mast cc ll-activating 
facto rs (Grattan e/ ai, 1986). T hc dc mo nstra tion that sera fi'om somc 
patients w ith positive skin tests also ca used ;/1 I/;I/,O hi stam ine release 
fro m basophil leukocytes of he~ l thy dono rs provided additional 
evidence of a role fo r circulating histamine-rcleas ing [;Ictors in the 
pathogenesis of chro nic urticaria (Grattan e/ ai, 1991; Hide el ai, 
1993). 
We identifi ed the basophil le ukocyte histaminc-rele'lsing activity 
in t h e sera of se lected patients with severe urticaria to be fun ctional 
autoantibodies directed against the high affinity IgE reccptor, FceRI 
(Hid e cf ai, 1993). T he autoantibodies were characte ri zed o n the 
basis of their ability to release histamine from hum an basophil 
leukocytes, the. effect of FcelU occupancy by IgE o n hista mine 
release, heat stability, and recovery in the IgG fraction o n protein G 
Manuscript rece ived April 19, 1995: revisedJanu<lry 2,1996 : accepted fo r 
publication Janll ary 10. 1996. 
Reprint requests to: Dr. Robert M. fiatT. Professorial Un it, St. John 's 
Institute of Dermatology. UMDS. St. T ho lll as' Hospital. La mbeth Palace 
Road, London SEl 7EH , Uni ted Kingd om. 
mediated. Preincubation of sera or the IgG fraction 
with a recombinant a-chain ofFceRI inhibited hista-
mine release from mast cells and basophils. Further 
studies with the mouse anti-human FceRIa antibody 
29C6 showed that Inast cells and basophils were 
similarly sensitive to IgG-mediated direct cross-link-
ing of FceRI, with 0.01-1.0 ""g/ml 29C6 evoking 
histamine release in each case. These studies demon-
strate that circulating levels of anti-FceRIa autoan-
tibodies mediate histamine release from skin mast 
cells ill vit/'o and, taken together with ill vivo evidence 
of mast cell degranulation following intradermal in-
jection of autologous serum, support the concept 
that anti-FceRIa autoantibodies are relevant to the 
pathogenesis of severe chronic urticaria in about 25% 
of patients. Key IVOJ'ds: basopiJiliellkocytes/lr;statllillelsk;II1 
FceRI. ] It",est Del'll,ato/ 106:1001-1006, 1996 
affin ity chro m atograph y. Conccntration-dependent inhibition of 
histamine re lease by preincubation of the patients' sera with the 
recombinant extracellular do main of the FceRl a-chain (sFcelUa) 
indicated that the cpi tope for antibody binding was on the a - chain 
of the receptor (Hide el ai, ( 993). We (Grnttan el ai, 1991) and 
others (Gruber e/ ai, 1988) havc also iden tified functional anti-l gE 
antibodies ill sera of a small minority of patients widl chromc 
urti caria . Histaminc re lease by these antibodies was dependent on 
IgE sensitization of the basophil le ukocytes, bl; t in initial studies 
they appeared to be of lesser signifi cance than anti-FceRl autoan-
tibodies in the pathogenesis of chronic urticaria (Hide cl ai, 1994). 
Ou r earlier studies (Hide Cf ai, 1993) on a limited number of 
se lected pa tients with severe urti ca ria did not clearly define the 
incidence of anti-FcelU autoan tibodies in chronic urticaria. The 
present data, derivcd fro m a much larger study of 1 6~ patients, 
indicate that approximate ly o ne quarter of patients With. severe 
chro nic urti caria have ci rcula ting histamine-releas ing 3ntl-FceRI 
autoantibodics. 
T he responsiveness of derma l mast ce lls to stimul ation by d irect 
cross-linkin g of FcelU by anti-FceRl au toantibodies is of central 
re levancc to the ro lc of d1Cse autoantibodies in the pathogeneSIs of 
chro nic urtica ria . Because sera containing functionally active an ti-
FceRJ autoantibod ies, as shown by ;/1 1/;/1'{) histam ine release from 
basophil leukocytcs, also ca used positive skin tests on autologous 
intradermal inj ection, the presumption is d,at anti-FceRl a autoan-
tibodies induce dermal mast degranulation and histamine release. 
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We now sh ow that se ra containing anti-FcERI O' a u toantibodies 
from urticaria patients, but n e ither sera from skin test-negative 
patients nor h ealthy subj e cts, cause histamin e r e lease from dermal 
mast celJ s in incubated human skin slices . 
M ATEIUALS AND METHODS 
Patients and Skin Testing Patients with severe chronic idiopathic 
urti caria, defined as recurrent wheal s lasti ng individually less than 24 hand 
occurring at least twice a week for more than 8 weeks, were studied. 
P~ltients \vith c lini cal ev idence o f urticarial vasc uliti s. cholinerg ic urticaria. 
or predominantly physica l urticaria were excluded. None of the patients was 
undergoing steroid or immunosuppressive therapy. Treatment with antihis-
tamines was stopped at least 48 h befo re the srudy. and no subject was taking 
long- acting antihi stamines. Control subj ects were healthy laboratory staff 
without a history of urti ca ria . Ethica l approval was obtained from the West 
Lambeth Health Authoriry Ethics Committee fo r all studies. 
Serum was obtained trom venous blood clotted at rOom temperature for 
20 min in glass tubes and centrifuged at 1050g for 15 mi n . Patients were 
skin-tested by intradermal injection of 50 fLI o f autologous serum in the 
vo lar forearm (Grattan et ai, 199 1). Whea l size was determined as the mean 
of the 111 3xiInunl dianlc te r, and the perpendicular dianlctc r wa s Jlw3 surcd at 
30 min. A positive autologous serum skin test was defined as a serum-
induced w hea l and Aare with a mean wheal diameter 2 mm greater than 
that, if any, resulting fro m a control injection of sa line. 
Histamine Release from Basophil Leukocytes Histamine release 
assays were performed as previously described (Hide et ai, 1993), using 
leukocytes from the blood of two healthy donors. BrieAy, the peripheral 
blood leukocytes containing about 1 % basophil s were obtained by mi>.;ng 3 
parts of heparinized blood with 1 part 1 'XI methyl cellulose in sa line. T h" 
leukocyte-ri ch supernatant was recovered and centrifug"d at 450g for 15 
III in to pellct the cells, which were washed twice in calcil1ln / nlag ncsiul11 
free assay buffer (10 mM HEPES, 137 mM NaCl , 2.7 mM KC I, 0.4 mM 
NaH2 PO., 0.03% human serum albumin and 5 mM glucose, pI-I 7.4). The 
leukocytes were resuspended in the complete assay buffer containing 2 mM 
ca lcium and 1 mM magnesium just prio r to incuba tion. Approx imately 3 X 
10" basophi l leukocytes were incubated at 37°C for 40 min in 0.1 ml of assay 
buffer containing a 2-fold d ilution of patient Or contro l serum or the serulll 
IgG fra ction . Dupli cate incubations were made for each experimental 
condition . The incubations were stopped by transfer of the tubes to iced 
water and addition of 0.8 ml of ice-cold assay buffer, and then centrifuged 
at 50Dg for 5 min at 4°C. The supernatants were decanted, the cell pellets 
resuspended in 0.9 ml of assay buffer, and 0. '1 ml of 3 M perchlo ric acid 
added to both the sup"rnatants and the resuspended cell suspensions. T he 
tubes w ere vortex mixed and centrifuged (8800g for 10 min) to remove 
precipitated protein , and the supernatants were analyzed for histanlinc . 
The two basophi l leukocyte donors were selected on the basis of the 
different degree of endogenous IgE sensiti zation of th eir basophil leuko-
cytes . The basophil s of donor 1 «1 .0 IU IgE/ml serum) were poorly 
sensitized , giving a low histamine release with polyclona l goat anti-h uman 
IgE (111000, E-chain specifi c: Sigma, Poole, UK) but responding to 
stimulation with the mouse monoclonal antibodies ('F7 and 29CG specifi c 
for the a -subunit of human FCERJ (Riske et ai , 1991) . In contrast, the 
basophi l leukocytes of donor 2 p 45 ru IgE/ml serum) released histamine in 
response to anti-lgE and 29C6 (noninhibited by bound IgE) but no t to 6F7 
(inhibited by bound IgE). Figure lB summari zes the hi stamine release 
properties of the basophil leukocytes from donors 1 and 2. 
Histalnil1c Rc1casc froJt:t Human Skin Mast Cells HlIIllan foreskin , 
obtained at circumcision (age range, '1 month to 21 years), was dissec ted 
free of subcutaneous tissue, cut in to strips 4-8 mm wide, and sliced using 
a hand microtome (Fisons, Loughborough, UK) . Three skin sli ces (0 .25-0 .5 
mm thi ck) were suspended in assay buffer and incubated at 37°C for 20 m.in 
Witll a 2-fold dilution o f serum or with contro l antibodies in a total volume 
of 0.1 ml. Each experimental condition was assayed in dupli cate. Released 
and residual histamine were assayed essentia lly as outlined above for 
basophil leukocytes. Following transfe.· of the supernatant, the residual 
histamine in the incubated skin sli ces was eff.ciently e>; tracted by treatment 
with 0.3 M perchlo ric acid at room temperature for 20 min with vo rtex 
mixing. Total hist3l11inc was usuall y greate r than 50 ng/assay tube and 
sponta.neo us release less than 3'Yo . 
Dctcrnlination of Net Histamine Release HistatTlin c was measured 
by an automated Auorometric assay (Siraganian, 1975), using a Perkin-
Elmer LS-5B Luminescence Spectrometer with a minimum detection limit 
of less than 1 ngl ml histamine . The released histamine in the supernatan t 
and residual histamine in the cell pellet were determined for each assay tube . 
Account was taken of the serUlll fluo rescence blank value wh en dctcnnining 
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Figure 1. Sera from 50% of patients with positive skin tests, but not 
sera from patients with negative skin tests, released histamine 
from basophil leukocytes. A: Sera from J 63 patients, identifi ed as skin 
test-positive (n = 98) or -negative (n = 65) , were assessed fo r their abili ry 
to release hi stamine from basophil leukocytes from two donors. Opell circles , 
sera that induced hi stamine release from basophils o f donor 1 or donor 2 or 
both donors: solid circles, sera that failed to release histamine Irom basophils 
of either donor. Data deriv ed from 15 experiments with donor 1 basophils 
and 13 experiments with donor 2 basophils. B (illset): The basophil 
leukocytes from donor I ~not IgE-sensitized) and donor 2 (lgE-sensitized) 
we re characterized by their release of histamine (means :!: SO, n = 5 
experim ents) in response to goat polyclonal anti-human IgE (1 / 1000) ("}lell 
bars) ; and the mouse anti-FcER.l ex monoclonal antibodies (50 ng/ ml) 6F7 
(lgE inhibited) (solid bars): and 29C6 (lgE not inhibited) (hatcherl bars). N ct 
hi stamine release induced by sera o r antibodies was calculated as described 
in Mnterials flO.d Meth"ds. The m edian to tal histamine per assay tube for donor 
1 basophil leukocytes was 56 ng (range, 37-81 ng: n = 15 experimen ts) , 
and for donor 2 basophils, 49 ng (range, 27- 94 ng; n = 13 experiments) . 
the supernata nt hi st:uninc content. T he SUI11 of the residu al and corrected 
supe rnatant hista mine va lu es gave the tot .. d hist.Jnlin c for e:Jch assa), rube. 
Histamine release is expressed as the percentage o f the total histamine 
content in each assay tube released fro m ti,e cells into the supernatant by the 
stirnulu s. and was corrected to g iv e the nct hi stall1ill C re lease by subtraction 
of the spontaneous hi stamine rel ease « 3'Vo) fo und when basophilleuko-
cytes or skin slices were inc ubated w ith buffe r alone . 
Isolation of Serum IgG Serum (0 .6 ml) was centrifuged through a 
0.45- fL111 po lyvinylidene diAuoride micl"Ocentrifuge filter tube (Whatman, 
Maidstone, UK), and the IgG fraction was purified by aff:iniry dtrom.tog-
raphy on a 1-1111 protein G column (HiTrap, Pharmacia Biotech , St Alban, 
UK) , fo llowing the manuf.1ctu rers' instructions except that e lu tion buffers 
were prepared without preservative. T he column eluent was monitored by 
UV absorbance at 280 11111 , and the IgG fracti on was co llected and 
concentrated by ultrafiltration using Centri con-30 microcollcentrators 
(Amicon, Gloucester, UK) . The retento te was recovered in 0.45-1111 assay 
buffer and a 2-fold di lution used in histamine release assays with human skin 
slices as described above. 
Neutralization of Histamine-releasing Activity by Recombinant 
Soluble Extracellular Fragment of FcElUex (sFceRlIl') Serum sam-
ples and IgG fractions were preincubated at 37°C for 30 min with 1 fLg /ml 
sFcEIUex in assay buffer prior to incubation with basophil leukocytes or skin 
slices . The sFcERl a was obta ined from the culture medium of stably 
transfected C hinese hamster ovary cell s (R.iske et al. 1991). 
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Statistics Paired t tests were used in statistical analysis . 
Materials The mouse monoclonal anti-human FCEIUa antibodies. 6F7 
and 29C6, and recombinant sol ub le extracellu lar fragment of the human 
FCERl a -chain , sFcERJa, were genera lis gifts from Drs. J. Hakimi. J. P. 
Kochan, and R . Chizzol1itc (Hoffi,"11 La-Roche, Nutie)' . NJ). Antibody 
6F7 is defined as being " inhibitory" on the basis d,at it inhibited IgE binding 
to a-chain protein and failed to immunoprecipitatc soluble IgE-n-chain 
complexes. On the other hand. 29C6 is "noninhibitory," because it docs 
not block IgE binding to a-chain protein but immunoprecipitates IgE-n-
chain complexes (Riske ct 0/, 1991). 
RESULTS 
Prevalence of Basophil Leukocyte Histamine-releasing Ac-
tivi ty in Sera of Autologous Serum Skin Test-Positive and 
-Negative Patients In a group of 163 pa tients w ith a clinical 
diagnosis of chronic idiopathic urticaria , 98 patients (60%) re-
sponded with a positive autologous se[tlm intradermal skin test. 
The sera from 47 of the skin test-positive patients (29% of all 
urticaria patients studied) evoked more than 5'y., histamine re lease 
from the basophil leukocytes of donor 1 or donor 2 or both donors 
(Fig lA) . T hirty- eight of these 47 sera evoked histamine release (35 
:t 19%, mean :t SD) fi'om the basophil le ukocytes of donor 1 
(poorly IgE- sensitized), indicative of anti-FCEIU autoantibodies. 
Twenty- eight of the 38 sera also caused histamine release (36 :t 
22%, mean ::!: SD) fro m leukocytes of donor 2 (endogenously 
IgE-sensitized) , indicating that, for the majo rity of sera , IgE sensi-
tization of the leukocytes did not substantially inhibi t histamine 
release. The sera from nine skin test-positive patients induced 
histamine release (23 :t 14'Yo , mean :t SD) only from dIe IgE-
sensitized basophils of donor 2, indicative of anti -IgE antibody-
mediated histamine release. Sera from 51 patients, although skin 
test-positive, fuiled to evoke significant histamine re lease (i.e., < 5% 
release) from basophil leukocytes of either donor. Only 3 of 65 sera 
from skin test-negative patients released histamine from the baso-
phil leukocytes of donor 2, with one of these also causing histamine 
release fi'om the leukocytes of donor t (Fig lA). Sera fi~om healthy 
control subjects (n = 19) did not indu ce histamine re lease from 
basophil leukocytes of e ither dono r (data not shown) . 
Characterization of Serum-induced Histamine Release 
frOnt Basophil Leukocytes T he sera of 12 patients (9 female, 3 
male; mean age::!: SD 37.4 :t 15.7 years) that gave positive 
autologous skin tests and evoked histami.ne release fi'o m the 
basophil leukocytes of dono r 1 were studied in more detail. All t 2 
sera induced > 30'X, histamine release from the non-l gE- sensitized 
basophil leukocytes of donor 1 (Fig 2A) . Preincubation of the sera 
with sFcEIUa (1 IJ-g/m l) inhibited histamine re lease by 82 :t 17% 
(mean :t SD, n = 12, P < 0 .001), inhibition bei.ng > 70% for 1 t of 
the 12 sera . These results indica te that the histamine-re leas ing 
activity in the paticnts' sera was mediated through the a - chain of 
the FceRI and that prior scnsitization of th e recepto r with IgE was 
not a prereq uisi te fo r hi stamin e release. 
As IgE aggregates capable of cross- linking FcElU and lor com-
plement could po tentiall y induce histamine re lease fi'ol11 basophil 
leukocytes, we heat-treated (56°C for 60 min) the 12 sera . Al-
though the reduction in histamin e release b y heat treatm ent was 
significant (p < 0.01 , paired t test) the magnitude of the reduction 
for most of the sera was small, 80 :t 17% (mean :t SD, n = 12) of 
the histamine-re leasing activity be ing retain ed (Fig 2B). T he 
reduction in histamine-releasing activity was < 30% for 10 of the 12 
patients, but two patients, C and D, showed substantial heat labili ty 
of 37 and 51%, respectively. T he same heat treatment of control 
serum from an atopic subject and of m yeloma IgE comple tely 
inhibited their ability to sensitize basophil leukocytes of donor :t . as 
assessed by the absence of histamiJ1e rele'lse in response to goat 
anti-human TgE stimul ation (results not shown), the reby demon-
strating that IgE was effectively denatured under the conditions 
used. T he heat stability of the histamine-releasing activity in the 
patien ts' se ra showed that TgE aggregates were not a maj o r 
component of the histamine-releasing activity. 
Eight of the 12 patients' se ra induced similar hista min e re lease 
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Figure 2. Characterization of histamine release from basophil 
leukocytes induced by sera from 12 autologous serum skin test-
positive patients . A: Inhibi tion o f SCflll11-induccd hi.staJnin c release fronl 
basophil leukocytes of donor 1 by preincubation of the paticnts' sera with 1 
/-Lg/ ml sFcEIll n. Solid bors. control sera; II ntellcd bnts. sera preincubated with 
sFaRIO'. Histamine release by control sera. 44.4 ::':: 9.5%; by sera prcincu-
bated with sFcERJ O'. 8.2 ::':: 8.1 'X, (means ::!: SO. p < O.OOl ). Total histamine 
per assay tube. 72 ng. B: T he effect of hcat trCatmenc (56 °C for 60 min) of 
sera on histamine release fi'om basophil leukocytes of donor 1. Solid bor.<. 
contro l sera; II ntclied bnrs. heatcd sera. Histamine release by control sera, 45. 1 
::':: 12.l %: heated sera, 36.3 ::':: 10.9% (Illeans ::':: SO. P < 0.01). Total 
histamine pcr assay tube. 47 ng. C: COlllparison of histanline release from 
basophil leukocytes of donor 1 (solid lla",), and donor 2 (I""eI, l,d bnrs). Total 
hi stamine per assay tube for donor 1. 52 ng; for donor 2. 63 ng. HistaJnine 
release by the mouse monoclonal antibodies 29C6 or 6F7(50 ng/ ml) used as 
controls ilre shown to the left. Bors show dlC Illeans of duplicate incubations. 
D ifrerences ill histanlinc release between dupli cates were always less than 
31%. 
fi'0 111 IgE nOllsensitized basophil leukocytes of donor 1 as from the 
IgE- sensitized basophi l leukocytes of dOllor 2 (Fig 2Q, indicating 
minimal inhibition of histamine release by receptor bound IgE. Sera 
offour patients (E, G,] , and L), however, released substantially less 
histam in e fi'om the IgE-sensir.ized basophil leukocytes (donol' 2) 
than fro m poorly sensitized basophil le ukocytes (donor 1) , a pattem 
of histamine re lease activity similar to that o btained with the mouse 
m onoclonal antibody 6F7, and suggesting that receptor-bound IgE 
may be partially inhi bi ting histamin e release by these sera. 
Histamine Release from Basophil Leukocytes and Skill 
Mast Cells Is Induced by Similar Concentrations. of t.he 
Mouse Monoclonal Antibodies 29C6 and 6F7 )-i1stamme 
release induced by the m ouse m onoclonal antibodies 6F7 or 29C6 
~rom basophi l leukocytes and frol11 mast cells in skin slices was 
compared (Fig 3) . Histamine was released from skin mast cells and 
basophil leukocytes by similar concentrations (0.01-1 IJ-g/ ml) of 
antibody 29C6 (Fig 3 , B and D). T he m aximum histamin e release 
from basop hil leukocytes was reached at 0.3 IJ-g/ ml an tibody, 
w he"eas for m"st cells, maximum release was above 1 IJ-g/ml, the 
highest concentration of antibody used in these experiments. T he 
basophil leukocytes of donor 1 (low serum IgE, poorly sensitized) 
are clearly more responsive to 6F7 than the basophils of the other 
do nors, 50 ng/ m l antibody causing 45% histamine release com-
pared with < 12% histamine re lease fo r the other donors. T he 
re lease of histamine fi'om dermal mast cells in response to 6F7 was 
also m ore va riable than for 29C6. aga in possibly a result of varying 
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Figure 3. Histamine release from basophil leukocytes and skin 
In3st cells is induced by sitnilar concentrations of the nlouse 
monoclonal antibodies 29C6 and 6F7. Basophil leukocytes from five 
healthy donors were stimulated with 6F7 (A) or 29C6 (B) in the concen-
tration range of 1 ng/ml to 1 fLg/ml antibody. The histamine re lease from 
the basophil leukocytes of donor 1 (ol'ell circles) and donor 2 (so lid circles) 
previously described are emphasized with solid lilies. The lower pands (C 
and D) compare histamine re leases from mast cells in skin sli ces in '10 
independent experiments, f,ve experiments with 6F7 (C) and five with 
29C6 (D), using concentration ranges simi lar to those for basophil leuko-
cytes. T he median tota l h.istamine per assay tube with basophil leukocytes 
was 76 ng (range, 46-120 ng: n = 5 experiments) and fo r skin sli ces. 67 ng 
(range. 20 - 200 ng; n = 10 experiments). 
degrees of IgE sensitization of FCE1U a on the mast cells or 
dilferences in responsiveness between different skin samples. 
Skin Test-Positive Sera Induced Histamine Release from 
Mast Cells in Incubated Skin Slices Sera from all 12 patients 
caused histamine release from dermal m ast cells in skin slices (Fig 
4A) that ranged from 4 to 34% in five separate experiments. 
Histamine release fro m different samples of skin varied consider-
ably, not o nl y with respect to repeated analysis of serum sampl es in 
separate experiments but also in response to stimulation by goat 
anti-lgE and the mouse anti-FcERla antibodies, 6F7 and 29C6. All 
sera, however, from skin test-negative urticaria patien ts (n = 20) 
and control hea lthy subjects (n = 22) re leased less than 3°/', of the 
histamine from mast cell s in skin slices (Fig 4B). 
Serum IgG-induced Histamine Release from Skin Mast 
Cells Was Inhibited by Preincubation of the IgG Fraction 
with sFcERIa T he histamine-releasing activity in six se ra (F, G, 
I, J, K, L) was studied in more d eta il. Preincubation of the 
heat- treated sera with sFcElUa inhibited histamine release from 
skin mast cells by 68 :': 23'Yu (mean :': SO, n = 6, P < 0.02), 
inhibition being > 72% fo r 5 of tbe 6 patients' sera. Afl:inity 
chrom atography of the sera o n protein G demonstrated that the 
histamine-releasing acti vity w as associated with the IgG fraction. 
Preincubation of the IgG fraction with sFcER.l c~ inhibited histamine 
re lease from m ast cells in skin slices by 78 :': 14% (mean :': SO, p = 
0.025, n = 6) (Fig 5) . T hese data are consisten t with the h ypo thes is 
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Figure 4 . Skin test- positive scra~ but not skin test-negative sera 
nor sera from healthy controls, induced histamine release from 
mast cells ill incubated skin slices. A: Sera from the 12 selected patients 
w ith positive scrlllll ski n tests were tested for 111:lSt cell histamine-releasing 
tlctivity in five cxpcrin lCnts. Ten se ra we re each assayed t\vicc in indepen-
dent experiments. two of til e sera were assaycd o nl y oll ce. a tota l of 22 
assays on f,ve sa noples of hu lTlan skin. e. serum sample: 0, goat lInti-lgE(lI 
250); 0 , 6F7 (100 ng/ml): 6 . and 29CG (100 ng/nol). Values for total 
hi sta mine per assay tube in expcrirnents ·1-5 were 57. 81, 167, 19. and 63 
ng. B: Failure of scm frono skin tes t-negative patients (n = 20) and healthy 
vo luntee rs (n = 22) to rei e<lsc histamine frolll skin IHast ccUs. Each serunl 
sample (e) . was tested in a single experiment with the data shown derived 
fro 111 fi ve cxpcrinlc n ts , the med ian tota l hi staminc pe r assay tube was 58 ng 
(range, 43-88 ng). R.elease of hi stamin e (med ians :':: range) by the conao\ 
antibodies. anti-IgE(11250) (D ): 6F7 (100 ng/nol) (0 ) ; and 29C6 (1 00 
ng/ rnl) (6 ): demonstrates reactivity of the skin mast cells in the !i,·e 
cxperimc n ts. 
that IgG autoan tibodi es in urtica ri a patients' sera can evoke hi sta-
mine re lease ti-om derm al m ast cells t1u·ough interaction wicb 
FCERI. 
DISCUSSION 
Functio nall y active anti-FcERl autoantibodies in sera of patients 
with chronic idiopathic urti ca ri a were initially identified by their 
abil ity to evoke histamine re lease from basophil le ukocytes of 
hea lthy do nors (I-lide cl nl, 1993). As cu taneo us wheal ing is the 
primary feature of chro nic, urti ca ria , the presumption was that 
dermal m ast ce lls also degranulate in response to cross-linking of 
FCEIU by autoa ntibod ies . with the release of histamine and other 
m ed ia tors in to the skin . T here arc many fun ctional differences, 
however, between Illast cells and basophil leukocytes, and it was 
impo rtant to dem o nstrate that skin mast ce ll s were equally respon-
sive to direct an ti body m edia ted cross-linking of FCERl . We have 
now shown that the circ ula ting leve ls of anti- FcER.rc~ autoantibod-
ies in pa tients w ith chro nic urti ca ri a are sufl-Icient to cause histamine 
release frOIll ski n m ast ce lls. Beca use purified prepara tions of skin 
m ast ce lls were not studied , we cannot d efi nitively conclude that 
anti-FcERla autoan ti bodies induce histamine re lease by direct 
in teractio n w ith mast ce ll s in the skin slices, although this is the 
m ost likely mechanism. T he re is a potential for interaction of 
anti-FcEIUa autoantibodies with Langerhans and dermal dendritic 
ce lls, w hich also express FCERIa (Maurer and Stingl, 1995) . 
Basophil le ukocyte histamin e-re leasing activity was found in a 
tota l of 47 (30%) of all patient's sera, and was associated with 3 
pos iti ve auto logous skin test. Data from IgE- sensitized and nonsen-
sitized basophil leukocytes indicated that histamin e re lease, for tbe 
majority of patients' sera, was no t dependent on IgE. We estimate 
the ratio of patients w ith anti-FaRIa to those with an ti-IgE 
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Figure 5. Serum IgG-induced histamine release from skill l11ast 
cells was inhibited by preincubation of the IgG fraction with 
sFcERla. T he IgG fraction, isolated fro m patients' scra by protein G 
chromatography, was prcincubated with assay buffer (so lid 1)(".5) o r 1 fJ.g/ ml 
sFcERla (hatched btlt:,) prior to assay of hjstamine-relcas ing activity from 
mast cells in skin slices. R.esults ar e for two independent cxperiments with 
IgG fractions from three patients tested in each. Net histamine release (m can 
:':: SD) expo 1.3.2 :!:: OA 1'Y, and 0.44 :!:: O.27'X, ; expo 2 . 13.3 :!:: 5.4% and 3.7 
:!:: 1.2%; control 'lIld sFcElU a, respecti vely. 29C6 (100 ng/ ml) was used as 
a positive contro l. Btlrs show the the means :!:: range of dupli cates. The tota l 
histamjne per assay tube was 271 ng in experiment I and 85 ng in 
experiment 2. 
autoantibodies to be approximate ly 4 to 1. A small minority of 
urticaria patients (2 /47 ) appeared to have autoantibodies of both 
types. The properties (heat stab ility, inhibition by sFcelUa, hista -
mine re lease from IgE-sensitized and nonsensitized basop hils, and 
isolation of the activity in the IgG fi';1ction) of the hista mine-
releasing activity in the sera of the J 2 patients se lected for m ore 
detailed study were compatible w ith anti-FaRia autoantibodies as 
the ca use o f histam ine re lease . 
The specificity of histamine-re leasing activity to patients with 
positive auto logous serum skin tests implies a causa l re lations h.i p to 
the patient's urticaria . O nly 3 (4.5%) of 65 sera classified as being 
skin test-negative released histamine from basophi l leukocytes. 
These three apparently aberrant o bservations primal'ily reflect 
equivocal skin tests that were classified as being negative by the 
clinician, rather than an unusual histamine-re leasing activity. It is 
possible that inadvertent injection of sera in to recently urtica ted 
skin, where m ast ce lls may be re frac tory to further activation , 
negated the skin tests. None of the sera fi'om skin test-negative 
patients (n = 20) nor those of healthy subj ects (n = 22) evoked 
histamine release fi'om dermal m ast ce ll s (Fig 4). Iml11un oprecipi-
tation and immunoblotting studies have con finned our fmding of 
autoreactivity against FceR.la in the IgG fi'action £.i·o m sera of some 
patients with urticaria (Fiebiger el II I , 1995). Anti-FceH..Ia autoan-
tibodies were not found in atopic dermatitis patients nor in healthy 
subjects, but their prevalence in othe r allerg ic or autoimmune 
disorders is not yet known. We have used the functiona l bioassay of 
histamine release from basophil leukocytes to identify sera conta in-
ing anti- FceRla autoantibodies. It is possible tha t some sera contain 
anti- FceRJa autoantibodies that fail to ac tivate the recepto r and 
release histamine and these would therefore not be detected by our 
methods. 
The releasabili ty of histamine from mast cells after cross-linking 
FceR1 may be a critica l param eter in the induction and the variable 
location ofwhea ling in the patients' skin . A Ilumber of criteria have 
been applied to describ ing histamine releasabili ty from basophil 
le ukocytes (MacG lashan, 1993) . In the context of autoantibody-
media ted urticaria , th e minimum concentration of antibody re-
quired to induce histamine release is pro bably of greater relevance 
than t he maximum hista mine release obtainable ill IIilro fr0 111 m ast 
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cells. Human skin contains substan tial amounts of histamine, up to 
20 jLg of histamine per gram of skin (Eady e/ nl, 1979; Benyon ef nl, 
1987), and only a sm all proportion of this would need to be released 
to cause a significant urticarial reaction . There was no appreciable 
difFerence between basophil leukocytes and mast cells in skin slices 
ill the minimum concentration of 29C6, 5-10 nglml, required to 
initiate histamine re lease. Dermal m ast ce lls, however, released a 
lower proportion of their tota l histamine than did basophil leuko-
cytes. T he maximum percentage histamine release from basophil 
leukocytes was achieved at approximately 0.3 jLg/ ml 29C6. but at 
greater than 1 jLg/ ml 29C6 fo r m ast cells in skin, which may reflect 
impaired access of the antibody to the mast ce ll s in incubated skin 
slices as w e ll as di iferences in responses between the two cell types. 
Histamine re lease stimulated by 6F7 was less consistent than that 
obtained with 29C6 for both dermal mast cells and basophil 
leukocytes, probably due to the degree of IgE sensitization of 
FceRL T he finding that both 6F7 (0.1 jLg/ml) and goa t anti-IgE 
(1/250) caused histamine release (16.9 :!: 8.9 and 19.8 :!: 13.1%, 
respectively, means :!: SD, n = 6) [rom th e same samples of skin 
suggests that the dermal m ast ce lls were n ot fully sensitized with 
IgE. It can be inferred [rom the results with the mouse monoclonal 
antibodies 29C6 and 6F7 t1,at the minimum concentration of 
anti-FaRI a au toantibodies required to initiate histamine release 
/Tom skin m ast ce lls is similar to that required to re lease histamine 
fro III basophi l leukocytes. T he finding of reduced numbers of 
circulating basophil leukocytes in some patients wi til chronic 
urtica ria (Grattan cf nl, 1991) indicates tha t autoantibodies arc 
present at functional concentrations in the patients' bl ood. Based on 
basophil leukocyte and skin sli ce histamine release dose-response 
cu rves usiJlg the monoclonal antibody 29C6 (Fig 3, B and D), we 
estimate that patients' sera con ta in ed histamiJl e-releasing 3nti-
FcelUa au toantibody equiva len t to 0.02-2 jLg/ ml 29C6. Serum 
histam ine-releasin g activity declined in [our patients in remission 
after plasmapheres is (Grattan el aI, 1992) . Further studies are in 
progress to dete rmine the correlation between serum anti-FcElUa 
au toantibodies levels and disease severity in patients that spontane-
ously remi t or have immunotherapy. 
Severe systemic symptom s arc relatively rare in chronic urticaria . 
Continual exposure to relatively low concentrations of autoanti-
bodies is likely to p roduce a chron ic low-l evel m ast ce ll activa tion, 
rather than an acute anaphylactic reaction as occurs when specific 
antigen is in troduced as a bolus in a previously sensitized individual. 
Access of autoan tibodies to the in terstitia l fluid surrounding skin 
m ast cells is probably an important factor in the induction of mast 
ce ll degranulation and subseq uent w hea l fo rm ation . T he y-globulin 
concentration in inte rsti tial fluid is about 30% of plasma , as reflected 
by lymph-draining hea lthy skin (Brand cl nl, 1994). Anti- FcERla 
autoantibodies in serum di lu ted to a similar extent release histamin e 
from basophil leukocytes and skin mast ce lls ill I,i l ro. Local changes 
in vascular permeabili ty by as yet unidentified f.1ctors may. be 
necessary fo r the initiation of IgG autoantibody-m ediated urtica-
tion. Histamine re lease i ll 11 ;''') could also act to amplify release by 
increasing vascular permeability and allowing increased extravasa-
tion of an ti- FcelU a autoantibodies. 
Our data support the concept that anti-FceR.I a autoantibodies 
arc re levant to the pathogenesis of chronic urticaria in about25% of 
patients. T he data show that about 50% of sera from skin test-
positive' pa tients fa iled to re lease histamine /Tom basophil leuko-
cytes. We have subseq uently shown that these sera contain a m ast 
cell-specific histamine~re l easing activity differing fi'om e ither anti-
FceJU or an ti-l gE au toantibodies (Kermani 10, Niimi N, Francis 
D M , O'Donlle ll B, Black AK, Hafizi S, Yacoub M , Greaves MW, 
Barr RM. C haracterization of a novel mast cell-specifi c histamine-
re leas ing activity in chronic id iopathic urtica ria. J lI /11cs I Derlllnfol. 
105:452, 1995, abstr.). O ur experience is that the auto logous serum 
skin test is a good predictor of mast ce ll histamine-releasing activity 
in the blood and that overall abo ut 60°/r, of patients witll severe 
chronic urti~a ri a hav~ circula ~ing histamine-re leas ing activity of 
one type or another. 
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